Literature DB >> 15452689

The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study.

Gordon L Klein1, Sunil J Wimalawansa, Gayathri Kulkarni, Donald J Sherrard, Arthur P Sanford, David N Herndon.   

Abstract

Bone loss is a known complication of severe burn injury. It is, in part, due to increased endogenous glucocorticoids that contribute to the reduction in bone formation and osteoblast differentiation, hypercalciuria secondary to hypoparathyroidism, and vitamin D deficiency. In this study we attempted to prevent post-burn bone loss by acute intravenous administration of the bisphosphonate pamidronate. We enrolled 43 children, with burns of > 40% total body surface area, in a randomized, double-blind, placebo-controlled study, administering the study drug within 10 days of burn injury and again 1 week later. Dual energy X-ray absorptiometry was performed prior to drug therapy, at hospital discharge and at 6 months post-burn. Urine specimens were obtained at baseline and discharge for determination of calcium and free deoxypyridinoline. Blood was obtained along with the urine specimens for measurement of intact parathyroid hormone (iPTH) and ionized calcium (Ca) levels. Following doxycycline labeling, intra-operative iliac crest bone biopsies were obtained, and bone histomorphometry was determined. At time of discharge there were no differences in total body bone mineral content (BMC), but lumbar spine BMC was significantly higher in the pamidronate group (P < 0.005). By 6 months post-burn the differences in lumbar spine BMC persisted, but, now, total body BMC was significantly higher in the pamidronate group (P < 0.05). Bone histomorphometry and levels of urine Ca and free deoxypyridinoline failed to show significant increases in bone formation or decreases in bone resorption. Pamidronate did not exacerbate the hypocalcemia in burn patients. In summary, acute intravenous pamidronate administration following burns may help to preserve bone mass, perhaps by inhibiting the glucocorticoid-induced apoptosis of osteoblasts and osteocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452689     DOI: 10.1007/s00198-004-1731-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  16 in total

1.  Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia.

Authors:  E D Murphey; N Chattopadhyay; M Bai; O Kifor; D Harper; D L Traber; H K Hawkins; E M Brown; G L Klein
Journal:  Crit Care Med       Date:  2000-12       Impact factor: 7.598

2.  Persistent hypoparathyroidism following magnesium repletion in burn-injured children.

Authors:  G L Klein; C B Langman; D N Herndon
Journal:  Pediatr Nephrol       Date:  2000-04       Impact factor: 3.714

3.  Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.

Authors:  Frank Rauch; Horacio Plotkin; Leonid Zeitlin; Francis H Glorieux
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

4.  Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy.

Authors:  D W Hart; D N Herndon; G Klein; S B Lee; M Celis; S Mohan; D L Chinkes; S E Wolf
Journal:  Ann Surg       Date:  2001-06       Impact factor: 12.969

5.  Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.

Authors:  L I Plotkin; R S Weinstein; A M Parfitt; P K Roberson; S C Manolagas; T Bellido
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  Persistence of muscle catabolism after severe burn.

Authors:  D W Hart; S E Wolf; R Mlcak; D L Chinkes; P I Ramzy; M K Obeng; A A Ferrando; R R Wolfe; D N Herndon
Journal:  Surgery       Date:  2000-08       Impact factor: 3.982

7.  Simulated weightlessness-induced attenuation of testosterone production may be responsible for bone loss.

Authors:  S M Wimalawansa; S J Wimalawansa
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

8.  Bone disease in burn patients.

Authors:  G L Klein; D N Herndon; T C Rutan; D J Sherrard; J W Coburn; C B Langman; M L Thomas; J G Haddad; C W Cooper; N L Miller
Journal:  J Bone Miner Res       Date:  1993-03       Impact factor: 6.741

9.  Histomorphometric and biochemical characterization of bone following acute severe burns in children.

Authors:  G L Klein; D N Herndon; W G Goodman; C B Langman; W A Phillips; I R Dickson; R Eastell; K E Naylor; N A Maloney; M Desai
Journal:  Bone       Date:  1995-11       Impact factor: 4.398

10.  Long-term reduction in bone mass after severe burn injury in children.

Authors:  G L Klein; D N Herndon; C B Langman; T C Rutan; W E Young; G Pembleton; M Nusynowitz; J L Barnett; L D Broemeling; D E Sailer
Journal:  J Pediatr       Date:  1995-02       Impact factor: 4.406

View more
  25 in total

1.  Burn Injury Has Skeletal Site-Specific Effects on Bone Integrity and Markers of Bone Remodeling.

Authors:  Matthew Hoscheit; Grant Conner; James Roemer; Aleksanhdra Vuckovska; Pegah Abbasnia; Paul Vana; Ravi Shankar; Richard Kennedy; John Callaci
Journal:  J Burn Care Res       Date:  2016 Nov/Dec       Impact factor: 1.845

Review 2.  Vitamin D in the new millennium.

Authors:  Sunil J Wimalawansa
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 3.  The role of the musculoskeletal system in post-burn hypermetabolism.

Authors:  Gordon L Klein
Journal:  Metabolism       Date:  2019-06-08       Impact factor: 8.694

4.  The effect of burn on serum concentrations of sclerostin and FGF23.

Authors:  Gordon L Klein; David N Herndon; Phuong T Le; Clark R Andersen; Debra Benjamin; Clifford J Rosen
Journal:  Burns       Date:  2015-04-25       Impact factor: 2.744

Review 5.  Burns: where has all the calcium (and vitamin D) gone?

Authors:  Gordon L Klein
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

6.  Pathophysiologic response to severe burn injury.

Authors:  Marc G Jeschke; David L Chinkes; Celeste C Finnerty; Gabriela Kulp; Oscar E Suman; William B Norbury; Ludwik K Branski; Gerd G Gauglitz; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

7.  Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury.

Authors:  Rene Przkora; David N Herndon; Donald J Sherrard; David L Chinkes; Gordon L Klein
Journal:  Bone       Date:  2007-05-08       Impact factor: 4.398

Review 8.  The calcium-sensing receptor as a mediator of inflammation.

Authors:  Gordon L Klein; Shawn M Castro; Roberto P Garofalo
Journal:  Semin Cell Dev Biol       Date:  2015-08-21       Impact factor: 7.727

9.  The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.

Authors:  E Cavalier; P Bergmann; O Bruyère; P Delanaye; A Durnez; J-P Devogelaer; S L Ferrari; E Gielen; S Goemaere; J-M Kaufman; A Nzeusseu Toukap; J-Y Reginster; A-F Rousseau; S Rozenberg; A J Scheen; J-J Body
Journal:  Osteoporos Int       Date:  2016-03-30       Impact factor: 4.507

10.  Pamidronate attenuates muscle loss after pediatric burn injury.

Authors:  Elisabet Børsheim; David N Herndon; Hal K Hawkins; Oscar E Suman; Matthew Cotter; Gordon L Klein
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.